Faculty

Institution

Unit

Venue

Mayer Davidson

Charles R. Drew University of Medicine and Science

Affiliations

Center Of Clinical Research

College of Medicine

Department Of Internal Medicine

Division Of Endocrinology, Metabolism, And Molecular Medicine

Institute Of Medical Sciences

NoneMayer Davidson is currently serving as a Center Of Clinical Research faculty at Charles R. Drew University of Medicine And Science.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Mayer Davidson

Charles R. Drew University of Medicine and Science

You can click a keyword to filter the displayed items

diabetes diabetes care health sciences diabetes therapies diabetes management medicine diabetes research diabetes mellitus physiology metabolism diabetic medicine insulin management chronic diseases pharmacology endocrinology insulin signaling blood glucose monitoring metabolic syndrome diabetes technology type 2 cell metabolism health care insulin delivery metabolic pathways clinical trials metabolic disorders cardiovascular disease liver physiology metabolic state pharmacotherapy disease management energy metabolism diabetes epidemiology metabolic regulation blood glucose obesity medicine growth hormone metabolic complications applied pharmacology clinical nutrition animal physiology endocrine mechanisms clinical pharmacology cardiovascular research molecular metabolism health systems liver disease metabolic health medical nutrition skeletal muscle muscle function minority population therapeutic efficacy treatment and prevention energy homeostasis cancer treatment glucose transport self monitoring u-500 regular insulin insulin resistance lipid metabolism diabetic patients diabetic retinopathy lipid synthesis nutrient physiology nutritional sciences endocrine research meta-analysis gestational diabetes universal health care impaired fasting glucose systematic review metabolic studies treatment algorithms updated meta-analysis pioglitazone exposure

Notable Scholarly Works

Notable Federal Grants

Collaborators

Comment on Pasanisi Et Al. Metformin Treatment With or Without Mediterranean Diet for the Prevention of Age-Related Diseases in People With Metabolic Syndrome: The Mememe Randomized Trial. Diabetes Care 2025;48: 265–272. Diabetes Care (2025)

obesity medicinediabetes caremedicinediabetes therapiesdiabetesmetabolic disordersmetabolic syndromemetabolic complicationsobesitymediterranean dietmetabolismmememe randomized trialnutritionhealth sciences

Nonlifestyle Treatment of Prediabetes. Clinical Diabetes (2025)

diabetes caremedicinediabetes therapiesdiabetesnonlifestyle treatmentdiabetes managementhealth sciences

Comment on Mittendorfer Et Al. Insulin Hypersecretion as Promoter of Body Fat Gain and Hyperglycemia. Diabetes 2024;73: 837–843. Diabetes (2024)

physiologydiabetesinsulin signalingbody compositionendocrinologymetabolic syndromediabetes researchmetabolic regulationmetabolic disordersobesitybody fat gainmetabolisminsulin hypersecretionmetabolic complicationshealth sciencescell metabolism

Definition of Overbasalization. Clinical Diabetes (2024)

Glycaemic Treatment of Newly Diagnosed Type 2 Diabetes. Diabetes Obesity and Metabolism (2024)

diabetes caremedicinediabetes therapiesdiabetesdiabetes mellitustype 2diabetes managementchronic diseaseshealth sciences

Real‐World Evidence for Computerized Insulin Dose‐Adjustment Algorithms in the Effective Use of Continuous Glucose Monitoring by Primary Care Clinicians. Diabetes Obesity and Metabolism (2024)

diabetes technologydiabetes carediabeteseffective usediabetes managementhealth informaticscontinuous glucose monitoringreal‐world evidencebiostatisticsblood glucose monitoringinsulin managementdigital healthhealth sciences

The Effective Use by Primary Care Clinicians of a Comprehensive Computerized Insulin Dose Adjustment Algorithm. Journal of Diabetes Science and Technology (2024)

diabetes technologymedicineindividualized medicinediabetesdiabetes therapiesdiabetes careinsulin deliveryeffective useprimary care cliniciansdiabetes managementprimary careinsulin managementhealth sciences

Beneficial Effect of Remote Glucose Monitoring and Computerized Insulin Dose Adjustment Algorithms Independent of Insulin Dose Increases in Sizeable Minorities of Patients. Clinical Diabetes (2023)

diabetes technologydiabetes careinsulin deliverydiabetesremote glucose monitoringdiabetes managementbeneficial effectbiostatisticsinsulin dose increasesblood glucose monitoringinsulin managementdigital healthhealth sciences

Human Insulin as an Antidote to the High Cost of Insulin: Clinical Insignificance of Pharmacokinetic/Pharmacodynamic Differences. Clinical Diabetes (2023)

medicinediabetes therapiespharmacologydiabetesinsulin deliveryhuman insulinhigh costapplied pharmacologypharmacokinetic/pharmacodynamic differenceshealth economicsinsulin managementhealth sciences

In Adults With Bmi ≥27 Kg/M 2 and Type 2 Diabetes, Adding Tirzepatide to a Lifestyle Intervention Increased Weight Loss at 72 Wk. Annals of Internal Medicine (2023)

physiologyobesity medicinemedicinediabetes therapiesdiabetesobesity managementchronic diseasesobesityweight disordersweight losslifestyle interventionmetabolic complicationshealth sciences

1
2
3
4
5
25
10 / page

Mayer Davidson

Charles R. Drew University of Medicine and Science

Affiliations

Center Of Clinical Research

College of Medicine

Department Of Internal Medicine

Division Of Endocrinology, Metabolism, And Molecular Medicine

Institute Of Medical Sciences

NoneMayer Davidson is currently serving as a Center Of Clinical Research faculty at Charles R. Drew University of Medicine And Science.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Mayer Davidson

Charles R. Drew University of Medicine and Science

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Nonlifestyle Treatment of Prediabetes. Clinical Diabetes (2025)

diabetes caremedicinediabetes therapiesdiabetesnonlifestyle treatmentdiabetes managementhealth sciences

Comment on Mittendorfer Et Al. Insulin Hypersecretion as Promoter of Body Fat Gain and Hyperglycemia. Diabetes 2024;73: 837–843. Diabetes (2024)

Definition of Overbasalization. Clinical Diabetes (2024)

Glycaemic Treatment of Newly Diagnosed Type 2 Diabetes. Diabetes Obesity and Metabolism (2024)

diabetes caremedicinediabetes therapiesdiabetesdiabetes mellitustype 2diabetes managementchronic diseaseshealth sciences

Real‐World Evidence for Computerized Insulin Dose‐Adjustment Algorithms in the Effective Use of Continuous Glucose Monitoring by Primary Care Clinicians. Diabetes Obesity and Metabolism (2024)

The Effective Use by Primary Care Clinicians of a Comprehensive Computerized Insulin Dose Adjustment Algorithm. Journal of Diabetes Science and Technology (2024)

Beneficial Effect of Remote Glucose Monitoring and Computerized Insulin Dose Adjustment Algorithms Independent of Insulin Dose Increases in Sizeable Minorities of Patients. Clinical Diabetes (2023)

Human Insulin as an Antidote to the High Cost of Insulin: Clinical Insignificance of Pharmacokinetic/Pharmacodynamic Differences. Clinical Diabetes (2023)

medicinediabetes therapiespharmacologydiabetesinsulin deliveryhuman insulinhigh costapplied pharmacologypharmacokinetic/pharmacodynamic differenceshealth economicsinsulin managementhealth sciences

In Adults With Bmi ≥27 Kg/M 2 and Type 2 Diabetes, Adding Tirzepatide to a Lifestyle Intervention Increased Weight Loss at 72 Wk. Annals of Internal Medicine (2023)

physiologyobesity medicinemedicinediabetes therapiesdiabetesobesity managementchronic diseasesobesityweight disordersweight losslifestyle interventionmetabolic complicationshealth sciences

1
2
3
4
5
25
10 / page